학술논문

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence
Document Type
article
Source
British Journal of Cancer. 122(8)
Subject
Pharmacology and Pharmaceutical Sciences
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Genetics
Prevention
Human Genome
Biotechnology
2.1 Biological and endogenous factors
Aetiology
Cancer
Adolescent
Adrenal Cortex Neoplasms
Adrenocortical Carcinoma
Age Factors
Age of Onset
Alcohol Dehydrogenase
Child
Child
Preschool
Female
Genes
p53
Genome-Wide Association Study
Humans
Incidence
Infant
Male
Polymorphism
Single Nucleotide
Tretinoin
Public Health and Health Services
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language
Abstract
BackgroundGenome-wide association studies (GWASs) have enriched the fields of genomics and drug development. Adrenocortical carcinoma (ACC) is a rare cancer with a bimodal age distribution and inadequate treatment options. Paediatric ACC is frequently associated with TP53 mutations, with particularly high incidence in Southern Brazil due to the TP53 p.R337H (R337H) germline mutation. The heterogeneous risk among carriers suggests other genetic modifiers could exist.MethodsWe analysed clinical, genotype and gene expression data derived from paediatric ACC, R337H carriers, and adult ACC patients. We restricted our analyses to single nucleotide polymorphisms (SNPs) previously identified in GWASs to associate with disease or human traits.ResultsA SNP, rs971074, in the alcohol dehydrogenase 7 gene significantly and reproducibly associated with allelic differences in ACC age-of-onset in both cohorts. Patients homozygous for the minor allele were diagnosed up to 16 years earlier. This SNP resides in a gene involved in the retinoic acid (RA) pathway and patients with differing levels of RA pathway gene expression in their tumours associate with differential ACC progression.ConclusionsThese results identify a novel genetic component to ACC development that resides in the retinoic acid pathway, thereby informing strategies to develop management, preventive and therapeutic treatments for ACC.